Xeloda is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Capecitabine.
Product ID | 0004-1100_291d4df7-44eb-4bc6-a04e-e057cac12144 |
NDC | 0004-1100 |
Product Type | Human Prescription Drug |
Proprietary Name | Xeloda |
Generic Name | Capecitabine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1998-04-30 |
Marketing Category | NDA / NDA |
Application Number | NDA020896 |
Labeler Name | Genentech, Inc. |
Substance Name | CAPECITABINE |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Nucleic Acid Sy |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1998-04-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020896 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1998-04-30 |
Marketing End Date | 2014-12-31 |
Marketing Category | NDA |
Application Number | NDA020896 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-04-30 |
Ingredient | Strength |
---|---|
CAPECITABINE | 150 mg/1 |
SPL SET ID: | a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0004-1100 | Xeloda | capecitabine |
0004-1101 | Xeloda | capecitabine |
53808-0411 | Xeloda | Xeloda |
0054-0271 | Capecitabine | Capecitabine |
0054-0272 | Capecitabine | Capecitabine |
0093-7473 | Capecitabine | Capecitabine |
0093-7474 | Capecitabine | Capecitabine |
0378-2511 | Capecitabine | capecitabine |
0378-2512 | Capecitabine | capecitabine |
16714-467 | CAPECITABINE | CAPECITABINE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XELODA 75241696 2200434 Live/Registered |
Hoffmann-La Roche Inc. 1997-02-13 |